switch semaglutide to tirzepatide Switching from dosage chart Switch to Tirzepatide in T2D

Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones

Across subgroups, the weight change was consistently larger for SGLT2i recipients than for GLP1-RA recipients

Microdosing GLP-1 for autoimmune conditions is an emerging area of interest, with some practitioners maintaining patients on very low doses primarily for anti-inflammatory benefits rather than weight management

Separately, it lists cloudiness, discolouration or visible particulates as signs to stop and contact the pharmacy or provider, treating those as red flags rather than as the only test

Another challenge, researchers say, is that symptoms of nutrient deficiency including fatigue, nausea, and irritability can overlap with the common side effects of GLP-1 medications, making problems harder to spot early